Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
TipRanks on MSN
Roche Exercises Option with Recursion Pharmaceuticals
An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...
Turns out Java can do serverless right — with GraalVM and Spring, cold starts are tamed and performance finally heats up.
Microsoft introduced a new video series that teaches Java developers how to build generative AI applications using modern ...
Zacks Investment Research on MSN
Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors
Recursion Pharmaceuticals (RXRX) closed at $5.91 in the latest trading session, marking a -6.19% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.23% for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback